Leonard Appleman
@LenAppleman
Followers
1K
Following
39K
Media
145
Statuses
1K
Genitourinary Oncologist #docswhorock
Pittsburgh, PA
Joined June 2011
RT @2StefanMoore: A final piece of advice from Holly Butcher - written the day before she passed away from cancer at just 27:. “It’s a stra….
0
7K
0
RT @neerajaiims: Breaking News from ph3 Embark trial👉Enzalutamide+ADT improve overall survival (OS) vs. ADT alone in Non-Metastatic HSPC #P….
0
63
0
RT @TiansterZhang: We enrolled #PDIGREE over 5 yrs including a pandemic, and in that time, 7 phase 3 trials read out that shaped the metast….
0
18
0
RT @drenriquegrande: I'm starting a thread about what you shouldn't miss this year at #ASCO25 if you want to see new findings in Bladder an….
0
18
0
RT @TheVinodLab: #mRNAvaccines for #PancreaticCancer (PDAC) PART4. 1. Out today in @Nature . 🧵👇🏽 . [1/23].
nature.com
Nature - In a phase 1 trial, patients with pancreatic ductal adenocarcinoma who were treated with surgery and bespoke neoantigen mRNA vaccines combined with anti-PD-L1 and chemotherapy exhibited...
0
824
0
RT @DrYukselUrun: Denosumab every 12 weeks vs. every 4 weeks in mCRPC: @Silke_Gillessen @APCCC_Lugano .📉 Lower risk of ONJ & tooth infectio….
0
54
0
RT @weldeiry: Solutions needed urgently if academic biomedicine is to survive; government and universities need to be creative and cut wast….
harvardmagazine.com
Three distinguished scientists on leaving academia to advance biomedical research
0
3
0
RT @bdermanmd: Prophylactic tocilizumab for myeloma bispecific antibodies;.CRS rate lowered to 14%!.No apparent effect on ICANS (though hig….
0
32
0
RT @DrDabestani: Vote @PGrivasMDPhD for #ASCO nominating committee member! .Share! #NapoleonDynamite.Use link: htt….
0
7
0
RT @LauraBukavinaMD: Vote for @DrRanaMcKay and @PGrivasMDPhD . you need to select ✌️ and they are both perfect for the job #ASCO.
0
9
0
RT @RepDeluzio: There's only one U.S. manufacturer of Grain Oriented Electrical Steel left, and it’s here in Western PA. We should protect….
0
8
0
RT @QianJanieQin: Dr. Saby George discussing Phase I/II of #pazopanib/alternating #bevacizumab in treatment naive metastatic RCC- met prima….
0
3
0
RT @shilpaonc: Great to see such strong representation from GU oncology for @ASCO elections for the nominating committee! .Exceptional cand….
0
10
0
RT @shilpaonc: Had a great discussion on NIAGARA, the 1st ph 3 trial establishing improved OS & EFS with peri-operative chemo-IO in MIBC w….
0
8
0
RT @ArndtVogel: 🔥we just published: An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.@ESMO_Open .http….
0
25
0
RT @dakidneydoc: SGLT2i use post AKI. 🤔 What is the effect on recurrent AKI ?. 🤔 What is the effect on progression of CKD ?. 🤗 Recurrent AK….
0
10
0
RT @VT_groundscrew: Thank you Boston College Football. Locker room was left clean with all the chairs put back in the lockers. VT apprecia….
0
1K
0
RT @PavlosMsaouel: 1/5 Excited to activate this week our fourth clinical trial designed for #RenalMedullaryCarcinoma (RMC). It will also se….
0
32
0
RT @shilpaonc: Congrats @slernerbcmedu1 & entire @SWOG S1011 team on this pivotal trial of extended lymphadenectomy vs standard procedure.….
0
7
0